Citation Impact
Citing Papers
MYC regulates the antitumor immune response through CD47 and PD-L1
2016 Science
A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression
2005 StandoutNobel
Regulation of alternative splicing by a transcriptional enhancer through RNA pol II elongation
2002 StandoutNobel
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
2010 StandoutNobel
Glucagon-like peptide-1: a potent regulator of food intake in humans
1999
Hallmarks of Cancer: The Next Generation
2011 Standout
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Synthetic Lethal Screening Identifies Compounds Activating Iron-Dependent, Nonapoptotic Cell Death in Oncogenic-RAS-Harboring Cancer Cells
2008
Inflammation and cancer
2002 StandoutNature
Role for the p53 homologue p73 in E2F-1-induced apoptosis
2000 StandoutNatureNobel
Influence of Metabolism on Epigenetics and Disease
2013 StandoutNobel
Arsenic inhibition of telomerase transcription leads to genetic instability
2001
HIF-Dependent Antitumorigenic Effect of Antioxidants In Vivo
2007 StandoutNobel
High-resolution cryo-electron microscopy structure of the Trypanosoma brucei ribosome
2013 StandoutNatureNobel
c-Myc-regulated microRNAs modulate E2F1 expression
2005 StandoutNature
Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors
2006 StandoutNobel
Elite and stochastic models for induced pluripotent stem cell generation
2009 StandoutNatureNobel
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties
1992 StandoutNobel
Telomeres and telomerase in cancer
2009
The biology of incretin hormones
2006 Standout
The 2–5 A system: Modulation of viral and cellular processes through acceleration of RNA degradation
1998
Telomeres Acquire Embryonic Stem Cell Characteristics in Induced Pluripotent Stem Cells
2009
AID is required for germinal center–derived lymphomagenesis
2007 StandoutNobel
The Hallmarks of Cancer
2000 Standout
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
2006 StandoutNobel
HIF-1 Inhibits Mitochondrial Biogenesis and Cellular Respiration in VHL-Deficient Renal Cell Carcinoma by Repression of C-MYC Activity
2007 StandoutNobel
Epstein-Barr Virus Provides a New Paradigm: A Requirement for the Immediate Inhibition of Apoptosis
2005
A Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected Cells
2014 StandoutNobel
Cell-Type Independent MYC Target Genes Reveal a Primordial Signature Involved in Biomass Accumulation
2011
Chapter 1 Physiological Roles of Ribosomal Protein S6: One of Its Kind
2008
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
2012 Standout
Induction of autophagy and inhibition of tumorigenesis by beclin 1
1999 StandoutNature
The c-Myc target gene network
2006
International Union of Pharmacology. XXXV. The Glucagon Receptor Family
2003
p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis
1999 StandoutNobel
The Physiology of Glucagon-like Peptide 1
2007 Standout
Regressing nude mouse grafts of burkitt's lymphoma×lymphoblastoid cell hybrids show deregulation of the c‐myc gene and expression of the EBV latent membrane protein
1991 StandoutNobel
HIF-1 Regulates Cytochrome Oxidase Subunits to Optimize Efficiency of Respiration in Hypoxic Cells
2007 StandoutNobel
Myc influences global chromatin structure
2006
Non-transcriptional control of DNA replication by c-Myc
2007 Nature
Ectopic Expression of the Catalytic Subunit of Telomerase Protects against Brain Injury Resulting from Ischemia and NMDA-Induced Neurotoxicity
2004
Short Dysfunctional Telomeres Impair Tumorigenesis in the INK4aΔ2/3 Cancer-Prone Mouse
1999 StandoutNobel
Oncogenic DNA viruses
2001 StandoutNobel
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
Transcriptional regulation and transformation by Myc proteins
2005
Infections as a major preventable cause of human cancer
2000
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
A common E2F-1 and p73 pathway mediates cell death induced by TCR activation
2000 StandoutNatureNobel
Control of c-myc Regulation in Normal and Neoplastic Cells
1991
Exendin-4 and exendin-(9–39)NH2: agonist and antagonist, respectively, at the rat parietal cell receptor for glucagon-like peptide-1-(7–36)NH2
1994
An Epstein-Barr Virus Anti-Apoptotic Protein Constitutively Expressed in Transformed Cells and Implicated in Burkitt Lymphomagenesis: The Wp/BHRF1 Link
2009
Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-α mediated repression of viral transcription and modification of the AP-1 transcription complex
1999 StandoutNobel
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
2009 StandoutNature
Nuclear reprogramming to a pluripotent state by three approaches
2010 StandoutNatureNobel
Stimulation of c‐MYC transcriptional activity and acetylation by recruitment of the cofactor CBP
2003
Epstein-Barr Virus-Encoded Bcl-2 Homologue Functions as a Survival Factor in Wp-Restricted Burkitt Lymphoma Cell Line P3HR-1
2009
The Immunoglobulin Heavy Chain Locus Control Region Increases Histone Acetylation along Linked c-myc Genes
1998
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Life with Oxygen
2007 StandoutScienceNobel
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
2008 StandoutNobel
Synchronous and sequential activation of latently infected Epstein-Barr virus genomes
1989
Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice
2007 StandoutNobel
Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes
2012 StandoutNobel
Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9
2002 StandoutNobel
Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells
1987
Evaluation of Myc E-Box Phylogenetic Footprints in Glycolytic Genes by Chromatin Immunoprecipitation Assays
2004
Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis
2010
Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1α to promote cell-cycle progression
2014 StandoutNobel
Different Patterns of Epstein-Barr Virus Latency in Endemic Burkitt Lymphoma (BL) Lead to Distinct Variants within the BL-Associated Gene Expression Signature
2012
Deregulated expression of the Myc cellular oncogene drives development of mouse “Burkitt-like” lymphomas from naive B cells
2004
Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems
2001 StandoutNobel
Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1
2007 StandoutNobel
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region
1985
Is the Epstein-Barr Virus Involved in Hodgkin's Disease?
1989
Multiple Single-Stranded cis Elements Are Associated with Activated Chromatin of the Human c-myc Gene In Vivo
1996
pVHL suppresses kinase activity of Akt in a proline-hydroxylation–dependent manner
2016 StandoutScienceNobel
Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription
1997 StandoutNobel
Viruses in Human Cancers
1991 StandoutScienceNobel
The Glucagon-Like Peptides
1999
Arsenic inhibition of telomerase transcription leads to genetic instability
2001
Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway
1998 StandoutNobel
Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis
2010
Promotion of direct reprogramming by transformation-deficient Myc
2010 StandoutNobel
Somatic hypermutation of the B cell receptor genesB29(Igβ, CD79b) andmb1(Igα, CD79a)
2003
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
Conservation of sequence and structure flanking the mouse and human β-globin loci: The β-globin genes are embedded within an array of odorant receptor genes
1999 StandoutNobel
Control of rDNA replication in Tetrahymena involves a cis-acting upstream repeat of a promoter element
1986 StandoutNobel
Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
1994
Nuclear and cytoplasmic AID in extrafollicular and germinal center B cells
2006
Works of Axel Polack being referenced
TPA-inducible Epstein-Barr virus genes in Raji cells and their regulation
1988
Cell cycle activation by c-myc in a Burkitt lymphoma model cell line
2000
Expression of cyclin D2 and D3 in lymphoid lesions
1999
Antagonistic effects ofc-myc and Epstein-Barr virus latent genes on the phenotype of human B cells
2001
Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma
1999
Control of cell growth by c-Myc in the absence of cell division
1999
Two deletions in the Epstein-Barr virus genome of the Burkitt lymphoma nonproducer line Raji
1984
Inducible loss of NF-κB activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes
2000
Burkitt Lymphoma in the Mouse
2000
Truncation does not abrogate transcriptional downregulation of the c-myc gene by sodium butyrate in Burkitt's lymphoma cells.
1987
The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
1991
Expression of cyclin D2 and D3 in lymphoid lesions
1999
Direct activation of TERT transcription by c-MYC
1999
Transcription of c-myc in human mononuclear cells is regulated by an elongation block.
1987
Regulatory elements in the immunoglobulin kappa locus induce c-myc activation and the promoter shift in Burkitt's lymphoma cells.
1993
Rat parietal cell receptors for GLP-1-(7-36) amide: northern blot, cross-linking, and radioligand binding
1994
Coordinated Regulation of Iron-Controlling Genes, H-Ferritin and IRP2 , by c-MYC
1999 Science
Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
1993
A complete set of overlapping cosmid clones of M-ABA virus derived from nasopharyngeal carcinoma and its similarity to other Epstein-Barr virus isolates
1984
c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.
1996